On Tuesday, the U.S. Food and Drug Administration proposed that food companies display nutrition labels on the front of the […]
FDA Proposes Putting Nutrition Labels on the Front of Packaged Foods in Health Push Read More »
Procter & Gamble (NYSE: PG) and Colgate-Palmolive (NYSE: CL) are among the defendants in six new lawsuits targeting the sale
Crest, Colgate Lawsuits Target Fluoride in Kids’ Toothpaste, Mouth Rinse Read More »
SAN FRANCISCO – Philips (NYSE: PHG) CEO Roy Jakobs said he still expects subdued demand in China this year due
On Monday, Johnson & Johnson (NYSE: JNJ) said it would buy neurological drug maker Intra-Cellular Therapies (NASDAQ: ITCI) for $14.6
Johnson & Johnson to Buy Neurological Drug Maker Intra-Cellular for $14.6 Billion Read More »
MADRID – On Monday, Mason Capital, the U.S.-based investment fund, said it had sent a letter to Spain’s stock market
Mason Capital Complains About Grifols’ Transparency to Spanish Regulator Read More »
Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing Eli
NEW YORK – Healthcare dealmakers gathering in San Francisco for the industry’s premier annual conference this week say they expect
Healthcare Dealmakers Eye M&A Resurgence in Second Trump Term Read More »
On Monday, GSK (NYSE: GSK), the British drugmaker, said it would pay up to $1.15 billion to buy Boston-based biopharmaceutical
GSK to Acquire US Biotech Firm IDRx for Up to $1.15 Billion Read More »
Pfizer’s (NYSE: PFE) experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of
Pfizer’s Bladder Cancer Therapy Meets Main Goal in Late-Stage Study Read More »
NEW YORK / BOSTON – On Wednesday, UnitedHealth Group (NYSE: UNH) shareholders said they requested the company prepare a report
Shareholders Urge UnitedHealth to Analyze Impact of Healthcare Denials Read More »
On Wednesday, Galapagos (NASDAQ: GLPG), the pharmaceutical firm, said it was planning to split into two listed entities by mid-2025,
Galapagos to Spin Off Innovative Medicines Business Read More »
ZURICH – On Wednesday, Roche said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics (NASDAQ: PSTX),
Roche to Complete $1.5 Billion Acquisition of Poseida Therapeutics Read More »
AMSTERDAM – Philips (NYSE: PHG), the healthcare technology company, has sold its Xiver computer chip subsidiary, the Telegraaf newspaper reported,
Philips Sells Small Chipmaking Subsidiary, Telegraaf Reports Read More »
NEW YORK – Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer (NYSE: PFE) COVID-19
Drugmakers to Hike US Prices on Over 250 Medications Starting January 1 Read More »
UnitedHealth Group (NYSE: UNH) and Amedisys (NASDAQ: AMED) have agreed to extend the deadline to close their $3.3 billion merger
UnitedHealth, Amedisys Extend Deadline to Close $3.3 Billion Deal Read More »
BioNTech (NASDAQ: BNTX) has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University
BioNTech Reaches Settlement with US Agency, UPenn Over COVID Vaccine Royalties Read More »
The U.S. Food and Drug Administration is proposing that cosmetic products containing talc should be tested using standardized methods to
US FDA Proposes Standardized Testing to Detect Asbestos in Talc Products Read More »
U.S. retail investor fund flows into Novo Nordisk (NYSE: NVO) surged 32-fold on Friday, as the Danish drugmaker’s weaker-than-expected obesity
Retail Investors Buy the Dip in Novo After Disappointing Weight-Loss Drug Data Read More »
The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from
US FDA Revokes Authorization for Four COVID Antibody Drugs Read More »
On Friday, the U.S. Food and Drug Administration approved Eli Lilly’s (NYSE: LLY) weight-loss treatment, Zepbound, for obstructive sleep apnea,
Lilly’s Weight-Loss Drug Zepbound Wins US FDA Approval for Sleep Apnea Read More »
LONDON/COPENHAGEN – On Friday, Novo Nordisk (NYSE: NVO) revealed disappointing results in a late-stage trial for its experimental next-generation obesity
LONDON/COPENHAGEN – On Friday, Novo Nordisk (NYSE: NVO) shareholders sought to find out why such a high number of patients
Novo Nordisk’s Dosing in CagriSema Obesity Drug Trial Puzzles Investors Read More »
The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals (NASDAQ: IONS) drug to treat a rare genetic disorder, making
Ionis Pharmaceuticals Gains FDA Approval for New Drug to Treat Rare Genetic Disorder Read More »
SHANGHAI – As Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) expand sales of their popular diabetes and weight-loss
In Weight Loss Battle, Novo and Lilly Face Growing Offensive from Licensed Copies Read More »
Copyright © 2025 abbonews.com
